ArticleWorld journal of gastroenterology2025
Imaging monitoring contributes to the "treat-to-target" strategy in the management of Crohn's disease.
Article in World journal of gastroenterology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Visual theranostic oral nanozymes for IBD from principles to preclinical design.Bioactive materials · 2026Review
- Abbreviated non-contrast magnetic resonance enterography for Crohn's disease: a reliability study.La Radiologia medica · 2026Article
- Practices and perceptions of imaging assessment in inflammatory bowel disease: a nationwide survey of physicians in Korea by the KASID Guidelines Taskforce Team.Intestinal research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Crohn's disease (CD) manifests as a chronic inflammatory condition of the gastrointestinal tract, featuring progressive and destructive full-thickness intestinal lesions that frequently result in irreversible structural damage. In recent decades, the treatment target for patients with CD has evolved from controlling symptoms to achieving sustained deep remission. While ileocolonoscopy remains the reference standard for the diagnosis and assessment of mucosal healing, cross-sectional imaging techniques, including magnetic resonance enterography, computed tomography enterography, and bowel ultrasound, provide comprehensive visualization of the small bowel, enabling evaluation of transmural inflammation and extraintestinal manifestations. Compared with endoscopic mucosal healing alone, transmural healing, assessed
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.